Cardiovascular Effects of CART Cell Therapy

Clinical trial NCT04026737 · COMPLETED

Trial details

NCT number: NCT04026737
Sponsor: Abramson Cancer Center at Penn Medicine
Status: COMPLETED
Study type: OBSERVATIONAL

Leukemia Lymphoma Cardiotoxicity Risk Factor, Cardiovascular Immunotherapy

Start date: 2019-07-22
Primary completion: 2022-11-16
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.